Global Point-of-Care Biosensors Market Growth 2023-2029
The global Point-of-Care Biosensors market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Point-of-Care Biosensors is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Point-of-Care Biosensors is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Point-of-Care Biosensors is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Point-of-Care Biosensors players cover Molecular Devices Corp., Abbott Laboratories, QTL Biodetection LLC, Biosensors International Group, Nova Biomedical, Medtronic, Siemens Healthineers AG, Johnson & Johnson and LifeScan, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Point-of-Care Biosensors Industry Forecast” looks at past sales and reviews total world Point-of-Care Biosensors sales in 2022, providing a comprehensive analysis by region and market sector of projected Point-of-Care Biosensors sales for 2023 through 2029. With Point-of-Care Biosensors sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Point-of-Care Biosensors industry.
This Insight Report provides a comprehensive analysis of the global Point-of-Care Biosensors landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Point-of-Care Biosensors portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Point-of-Care Biosensors market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Point-of-Care Biosensors and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Point-of-Care Biosensors.
This report presents a comprehensive overview, market shares, and growth opportunities of Point-of-Care Biosensors market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Thermal
Piezoelectric
Electrochemical
Optical
Segmentation by application
Fertility/Pregnancy
Glucose Testing
Hb1Ac Testing
Infectious Disease
Cardiology and Oncology
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Molecular Devices Corp.
Abbott Laboratories
QTL Biodetection LLC
Biosensors International Group
Nova Biomedical
Medtronic
Siemens Healthineers AG
Johnson & Johnson
LifeScan, Inc.
TDK Corporation
Molex LLC
Zimmer & Peacock AS
Koninklijke Philips N.V.
GE Healthcare
Bio-Rad Laboratories Inc.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Point-of-Care Biosensors market?
What factors are driving Point-of-Care Biosensors market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Point-of-Care Biosensors market opportunities vary by end market size?
How does Point-of-Care Biosensors break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Please note: The report will take approximately 2 business days to prepare and deliver.